MT CSI Advisory Memorandum of 2015-11-30
Health Insurer Obligations - Utilization Review, Internal Appeal, and External Review
COMMISSIONER OF SECURITIES & INSURANCE
MONICA J. LINDEEN
COMMISSIONER
OFFICE OF THE MONTANA
STATE AUDITOR
ADVISORY MEMORANDUM
To:
All Health Insurance Carriers
From:
Monica J. Lindeen, Commissiooer of Securities and Insurance
/
Office of the Montana State X,uditor
Date:
November 30, 201 5
HEATH INSURER OBLIGATIONS -
UTLIZATION REVIEW, INTERNAL APPEAL, AND EXTERNAL REVIEW
In 2015, the Montana Legislature passed Senate Bill 83 (SB83), now codified in Title 33,
Chapter 32 of the Montana Code Annotated. SB83 adopted versions of three National
Association of Insurance Commissioners (NAIC) model acts, including the Utilization
Review and Benefit Determination Model Act, the Health Carrier Grievance Procedure
Model Act, and the Uniform Health Carrier External Review Model Act. The legislation
takes effect on January 1, 2016. The Office of the Montana State Auditor,
Commissioner of Securities and Insurance (CSI), issues this memorandum to provide
health insurers with prospective guidance as to new reporting, filing, and disclosure
obligations applicable to health insurers as a result of SB83.
Annual Reporting Deadlines
SB83 requires health insurers to provide to the CSI annual reports relating to both
utilization review and internal appeals (also known as grievances). Section 33-32-
207(3) requires annual filing of a summary of utilization review program activities.
Section 33-32-306(7) requires a similar annual filing with respect to internal appeals.
Insurers must file both reports in a format specified by the CSI.
Health insurers will be required to file their first utilization review and internal appeal
annual reports no later than March 31 , 2017. These reports shall reflect insurer
Phom': l -800-332-61-lS / (-106)-l-l-l-20-lO / Main ~ax: (-l06)-l-l-l-'.i-l97
Securities F<1>..: (106)-llLi558 / PllS l'o\: (-106)-l-l-l-1980 / l.egc1l l·a\: (-l06) -l-l-l-'.i-l99
8-lO Helena A\·e., Helena \1T '19601
\Veb<-ite: \\"W\\ .c<-i.mt.gu\'
F-l'vla il: c-.i@mt.gm·
utilization review and internal appeal
annual reports no later than March 31 , 2017. These reports shall reflect insurer
Phom': l -800-332-61-lS / (-106)-l-l-l-20-lO / Main ~ax: (-l06)-l-l-l-'.i-l97
Securities F<1>..: (106)-llLi558 / PllS l'o\: (-106)-l-l-l-1980 / l.egc1l l·a\: (-l06) -l-l-l-'.i-l99
8-lO Helena A\·e., Helena \1T '19601
\Veb<-ite: \\"W\\ .c<-i.mt.gu\'
F-l'vla il: c-.i@mt.gm·
Health Insurer Obllgat1ons - Ut1l1zat1on Reviews,
Internal Appeals, and External Reviews
Page 2
experience during the calendar year 2016. The CSI will not require annual reporting
prior to March 31, 2017, to allow insurers to collect an entire year of data before the
initial report. As the reporting deadline approaches, the CSI will issue guidance
regarding the appropriate format of the ut1l1zat1on review and internal appeal annual
reports.
Internal Appeal Documentation Filing
Section 33-32-307 also requires health insurers to file extensive documentation relating
to internal appeals This documentation includes copies of the insurer's written internal
appeal procedures, including applicable forms used to process such requests, and a
description of those internal appeal procedures, which must be included in policy
documents §33-32-307(1), (4) The CSI requires that all health insurers doing
business 1n Montana file these materials with the CSI no later than January 1, 2016
Insurers must file this documentation either ema1l1ng it in .pdf format to SBarrv@mt gov,
or by mailing 1t to. Office of the Montana State Auditor, attn Shanni Barry, 840 Helena
Avenue, Helena, MT 59601
Form Disclosures
SB83 requires disclosure in policy documents of health insurer procedures relating to
ut1l1zation review, internal appeal, and external review. §§ 33-32-217, 33-32-307, 33-
32-423. The CSI will not at this time prescribe spec1f1c language, or a spec1f1c format,
which insurers must use to satisfy these disclosure requirements
n Shanni Barry, 840 Helena
Avenue, Helena, MT 59601
Form Disclosures
SB83 requires disclosure in policy documents of health insurer procedures relating to
ut1l1zation review, internal appeal, and external review. §§ 33-32-217, 33-32-307, 33-
32-423. The CSI will not at this time prescribe spec1f1c language, or a spec1f1c format,
which insurers must use to satisfy these disclosure requirements. See § 33-32-423
(external review disclosure must "be in a format prescribed by the [CSI]."). Instead, the
CSI has developed a document setting forth 1nformat1on insurers must provide 1n policy
documents. See Exhibit A This document sets forth the m1n1mum required disclosure;
insurers are encouraged to include such additional 1nformat1on regarding these topics
as is necessary to educate insureds regarding their rights and obl1gat1ons.
Section 33-32-423(2)(b) requires that the external review disclosures include a
statement advising the covered person of the right to file a request for external review
with the CSI. This conflicts with other applicable law, which requires that such requests
be filed directly with the health insurer. See§§ 33-32-410(1 ), 33-32-411 (1 ), 33-32-
412(1) The CSI may waive a particular prov1s1on found in an insurance policy form if
the prov1s1on 1s "unnecessary for the protection of the insured and inconsistent with the
purposes of the policy" § 33-15-301(1)(a). Additionally, a policy may not contain a
provision "inconsistent with or contradictory to any standard or uniform prov1s1on," but
the CSI may approve a suitable substitute. § 33-15-301 (2).
SI may waive a particular prov1s1on found in an insurance policy form if
the prov1s1on 1s "unnecessary for the protection of the insured and inconsistent with the
purposes of the policy" § 33-15-301(1)(a). Additionally, a policy may not contain a
provision "inconsistent with or contradictory to any standard or uniform prov1s1on," but
the CSI may approve a suitable substitute. § 33-15-301 (2).
Health Insurer Obligations - Ut1l1zat1on Reviews,
Internal Appeals, and External Reviews
Page 3
The CSI finds that the required disclosure found 1n § 33-32-423(2)(b) is unnecessary,
and inconsistent with and contradictory to the more specific external review procedures
disclosed elsewhere in the policy documents. Therefore, in place of the disclosure
required under§ 33-32-423(2)(b), health insurers should provide a substitute provision.
This provision should note that external reviews are filed with the insurer and should
provide the insurer's contact 1nformat1on, but 1n all other respects should mirror the
disclosure required under§ 33-32-423(2)(b).
Experimental/lnvest1gat1onal External Review - Timing
The CSI has 1dent1fied a drafting error 1n § 33-32-412, which addresses external reviews
relating to expenmental/1nvest1gat1onal adverse benefit determinations. Subsection (11)
states
(11) W1th1n 1 business day after the receipt of the notice of assignment to
conduct the external review pursuant to subsection (9), the assigned
independent review organization shall·
(a) select a clinical peer, or multiple peers 1f medically appropriate
under the circumstances, to conduct the external review; and
mental/1nvest1gat1onal adverse benefit determinations. Subsection (11)
states
(11) W1th1n 1 business day after the receipt of the notice of assignment to
conduct the external review pursuant to subsection (9), the assigned
independent review organization shall·
(a) select a clinical peer, or multiple peers 1f medically appropriate
under the circumstances, to conduct the external review; and
(b) make a dec1s1on, based on the opinion of the clinical peers, to
uphold or reverse the adverse determination or final adverse
determination.
Subsection (11 )(b) 1s 1n error for two reasons. First, an IRO cannot reasonably receive
an external review assignment, select clinical peers, and reach a determination within 1
business day. Second, § 33-32-412 sets forth the correct review t1meframes elsewhere
Spec1f1cally, § 33-32-412(20) and (22) provide clinical peer response and IRO
determ1nat1on t1meframes for both standard and expedited external reviews relating to
experimental/1nvest1gational insurer determinations. Therefore, the CSI advises
insurers and IROs to disregard the timeframe contemplated in § 33-32-412(11 )(b), and
to instead adhere to the timeframes described elsewhere in the statute.
For any questions regarding this advisory memorandum, call the CSI Legal Bureau at
(406) 444-2040
Senate Bill 83: Insurer Disclosure Guidelines
Utilization Review: Title 33, Chapter 32, Part 2
Mont. Code Ann. § 33-32-217: Certificate of coverage and member handbook must
contain clear and comprehensive utilization review procedures, including the
procedures for obtaining review of adverse determinations, and a statement of insured
nghts and responsibilities with regard to those procedures
Senate Bill 83: Insurer Disclosure Guidelines
Utilization Review: Title 33, Chapter 32, Part 2
Mont. Code Ann. § 33-32-217: Certificate of coverage and member handbook must
contain clear and comprehensive utilization review procedures, including the
procedures for obtaining review of adverse determinations, and a statement of insured
nghts and responsibilities with regard to those procedures.
Polley documents must include the following information regarding ut1lizat1on review:
•
State that the insured has the right to request ut1l1zat1on review, 1nclud1ng in
cases involving urgent care services
•
Provide the insured a toll-free or collect call telephone number for the insurer's
utilization review staff
•
Disclose the following ut1lizat1on review deadlines, within which the insurer must
complete its review·
o For prospective determinations
o For retrospective determinations
o For expedited determinations
o The insurer may seek a 15-day deadline extension for prospective and
retrospective determinations.
•
Explain how to appeal an adverse determ1nat1on, such as an adverse ut1l1zation
review determination.
Internal Appeal: Title 33, Chapter 32, Part 3
Mont. Code Ann. § 33-32-307: A health insurer shall use written procedures for
recewing and resolving grievances . .. [such procedures] must be included in or
attached to evidence of coverage.
Policy documents must include the following information regarding internal appeals
(also known as grievances):
•
Disclose the right of the insured to an internal appeal of an adverse
determination.
•
State that the consumer has the right to contact the Office of the Montana State
Auditor, Commissioner of Securities and Insurance (CSI), for assistance with an
appeal, and provide the CSl's address and telephone number
•
Provide the address and telephone number of the insurer's internal appeals staff.
•
State that the consumer has 180 days to request an internal appeal of an
adverse determ1nat1on.
Exh1b1t A
1
has the right to contact the Office of the Montana State
Auditor, Commissioner of Securities and Insurance (CSI), for assistance with an
appeal, and provide the CSl's address and telephone number
•
Provide the address and telephone number of the insurer's internal appeals staff.
•
State that the consumer has 180 days to request an internal appeal of an
adverse determ1nat1on.
Exh1b1t A
1
•
State that the ind1v1dual conducting the review shall be independent and
impartial.
•
State that the insured has the right to
o Submit additional information 1n support of his or her appeal.
o Request, free of charge, copies of the materials relating to the request for
benefits
•
Disclose the following internal appeal deadlines, w1th1n which the insurer must
complete its review:
o Standard prospective appeal
o Standard retrospective appeal
o Expedited appeal
External Review (ER): Title 33, Chapter 32, Part 4
Mont. Code Ann. § 33-32-423 Each insurer shall include a description of ER
procedures in or attached to the policy, certificate, membership booklet, out/me of
coverage. or other evidence of coverage
Policy documents must include the following information regarding external review
•
State that the insured may request an external review of an adverse
determ1nat1on involving "an issue of medical necessity, appropriateness, health
care setting, level of care, or level of effectiveness "
•
State that the insured has 120 days following the adverse determination to
request external review.
•
State that the insurer is required to disclose any information or documentation
that insurer relied upon when making their decision
•
Explain how to submit a request for external review, 1nclud1ng that for cases
1nvolv1ng expedited review, the insured may make the request orally.
•
Provide the CSI address and telephone number (and spec1f1cally state that the
CSI is available to assist consumers with their internal and external appeals).
•
Explain the external review process, 1nclud1ng
ed upon when making their decision
•
Explain how to submit a request for external review, 1nclud1ng that for cases
1nvolv1ng expedited review, the insured may make the request orally.
•
Provide the CSI address and telephone number (and spec1f1cally state that the
CSI is available to assist consumers with their internal and external appeals).
•
Explain the external review process, 1nclud1ng.
o The case will be assigned to an 1mpart1al independent review organ1zat1on
(IRO)
o The insured may submit add1t1onal 1nformat1on to support claim
o IRO, not insurer, will make final determination
•
Disclose the following external review deadlines, within which the IRO must
complete its review (these deadlines run from the day the IRO receives the
request):
o Standard external review
o Expedited external review
Exhibit A
2